Stay updated on Safety and Efficacy of Aflibercept in AMD Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Aflibercept in AMD Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added a consolidated Locations section listing all study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Maryland, Michigan, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Texas, Utah, Virginia, Washington, West Virginia). Updated the revision to v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T14:49:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The Publications section wording was updated to indicate that publications are automatically filled from PubMed and may not be about the study, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:33:14.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Removed the site-wide government funding notice about information currency and NIH Clinical Center operations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:26:01.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Two screenshots display the same NCT04126317 CANDELA study record with minor layout variations. Core study details such as objectives, design, eligibility criteria, and outcome measures remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:29:57.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    4%
    Check dated 2025-10-06T06:43:36.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:20:29.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Aflibercept in AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.